Ophthalmic Disease Therapeutics Market: How the Business Will Grow in 2026? Prominent Players: Merck & Co., Inc., Pfizer, Inc., Novartis AG, Allergan plc, F. Hoffmann-La Roche AG, Regeneron Pharmaceuticals, Inc., Santen Pharmaceutical Co., Ltd., Bayer AG,

The global ophthalmic disease therapeutics market is projected to reach US$ 47,831.3 Mn by 2026. This growth is attributable to increased funding by private and public organizations to conduct research and development (R&D) on ocular disorders. This information was published in a report, titled "Ophthalmic Disease Therapeutics Market: Global Market Analysis, Insights and Forecast, 2018-2026" which offers valuable insights into the drivers influencing growth of the market. As per the report, the global market is anticipated to report a CAGR of 6.1% during the forecast period. Furthermore, the report found that the market was valued at US$ 29,504.8 Mn in the year 2018.

The report covers:

o Global Ophthalmic Disease Therapeutics Market trends, with detailed analysis on consumer trends & manufacturer trends.
o Overview on supply analysis covering trends across raw material suppliers, technology providers and distributors.
o Key areas of investments identifying market opportunities and challenges in forecast timeframe.
o Competitive analysis of the industry players along with the overview on strategic management.
o Comprehensive company profiles of the major industry players.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/ophthalmic-disease-therapeutics-market-100441

Leading Players operating in the Ophthalmic Disease Therapeutics Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

o Merck & Co., Inc.
o Pfizer, Inc.
o Novartis AG
o Allergan plc
o F. Hoffmann-La Roche AG
o Regeneron Pharmaceuticals, Inc.
o Santen Pharmaceutical Co., Ltd.
o Bayer AG
o Bausch & Lomb, Inc.
o Others

Asia Pacific to Create Ample Growth Opportunities by 2026
North America dominated the global ophthalmic disease therapeutics market in 2018 and was valued at US$ 12037.9 Mn. The rising prevalence of retinal disorders especially in the U.S. is the chief driver of the market in this region. As per the National Eye Institute, presently around 3 million people in the U.S. alone are suffering from glaucoma and this number is projected to reach 4.2 Mn by 2030. Also, the country witnesses recent launch of ophthalmic treatments, which is further encouraging growth in the market.
The rising disposable income among people in Asia Pacific is expected to create growth opportunities in the market. In addition to this, increasing awareness about early diagnosis of ophthalmology enables growth of the market in this region. Governments in the region are focusing on R&D investments to improve ophthalmic disease treatment. These factors are expected to augment growth in the market by 2026.

Segmentation of the Global Ophthalmic Disease Therapeutics Market
By Disease Indication
o Glaucoma
o Open Angle Glaucoma
o Angle Closure Glaucoma
o Others
o Retinal Diseases
o Diabetic Macular Edema
o Macular degeneration
o Diabetic Retinopathy
o Retinal Vein Occlusion
o Others
o Dry Eye Disease
o Allergy & Infections
o Others
By Drug Class
o Anti-inflammatory
o Anti-infectives
o Anti-VEGF
o Anti-glaucoma
o Beta Blockers
o Prostaglandins
o Alpha Adrenergic Agonists
o Carbonic Anhydrase Inhibitors
o Combination Drugs
o Others
By Dosage Form
o Solid
o Liquid
o Semi-solid
By Distribution Channel
o Hospital Pharmacy
o Retail Pharmacy
o Online Pharmacy
By Geography
o North America (USA and Canada)
o Europe (UK, Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
o Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
o Latin America (Brazil, Mexico, Rest of Latin America)
o Middle East & Africa (GCC, South Africa, Rest of the Middle East & Africa)

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/ophthalmic-disease-therapeutics-market-100441

About Us:

Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights(TM) we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:
Fortune Business Insights(TM) Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Linkedin | Twitter | BLogs

This release was published on openPR.